Financials Med Paper S.A.

Equities

MDP

MA0000012593

Paper Products

End-of-day quote Casablanca S.E. 06:00:00 2024-04-28 pm EDT 5-day change 1st Jan Change
20 MAD -1.48% Intraday chart for Med Paper S.A. -2.91% -2.39%

Valuation

Fiscal Period: December 2018 2019 2021 2022
Capitalization 1 53.98 51.65 56.14 130.4
Enterprise Value (EV) 1 269.4 256.2 229.6 321.8
P/E ratio - -8.82 x 5.92 x 17.5 x
Yield - - - -
Capitalization / Revenue 0.69 x 0.63 x 0.71 x 0.97 x
EV / Revenue 3.43 x 3.11 x 2.91 x 2.39 x
EV / EBITDA - - 137,944,019 x 17,211,685 x
EV / FCF - - 28,731,292 x -4,577,702 x
FCF Yield - - 0% -0%
Price to Book - -1.35 x -1.5 x 6.3 x
Nbr of stocks (in thousands) 2,583 2,583 2,583 4,784
Reference price 2 20.90 20.00 21.74 27.25
Announcement Date 4/24/20 4/24/20 5/5/23 5/5/23
1MAD in Million2MAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2021 2022
Net sales 1 78.5 82.25 78.99 134.7
EBITDA - - 1.665 18.7
EBIT 1 -12.09 -0.5379 -2.536 13.79
Operating Margin -15.4% -0.65% -3.21% 10.23%
Earnings before Tax (EBT) 1 -10.97 -5.358 9.949 7.968
Net income 1 -11.38 -5.857 9.484 7.429
Net margin -14.5% -7.12% 12.01% 5.51%
EPS - -2.268 3.672 1.553
Free Cash Flow - - 7.993 -70.3
FCF margin - - 10.12% -52.18%
FCF Conversion (EBITDA) - - 480.12% -
FCF Conversion (Net income) - - 84.27% -
Dividend per Share - - - -
Announcement Date 4/24/20 4/24/20 5/5/23 5/5/23
1MAD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2021 2022
Net Debt 1 215 205 173 191
Net Cash position 1 - - - -
Leverage (Debt/EBITDA) - - 104.2 x 10.24 x
Free Cash Flow - - 7.99 -70.3
ROE (net income / shareholders' equity) 42.6% 16.6% -22.5% -89.2%
ROA (Net income/ Total Assets) -2.6% -0.11% -0.53% 2.83%
Assets 1 438.1 5,133 -1,788 262.5
Book Value Per Share - -14.80 -14.50 4.330
Cash Flow per Share - 0.1500 0.3100 0.0900
Capex - - - 7.78
Capex / Sales - - - 5.78%
Announcement Date 4/24/20 4/24/20 5/5/23 5/5/23
1MAD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. MDP Stock
  4. Financials Med Paper S.A.